Cited by 204Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.

A role for tau at the synapse in Alzheimer’s disease pathogenesis

Pooler, Amy M., Noble, Wendy, Hanger, Diane P.·2014·Neuropharmacology

DOI 10.1016/j.neuropharm.2013.09.018

Open this paper in CoChat — free account

Abstract

Alzheimer's disease (AD) is characterized by brain deposition of amyloid plaques and tau neurofibrillary tangles along with steady cognitive decline. Although the mechanism by which AD pathogenesis occurs is unclear, accumulating evidence suggests that dysfunction and loss of synaptic connections may be an early event underlying disease progression. Profound synapse degeneration is observed in AD, and the density of these connections strongly correlates with cognitive ability. Initial investigations into AD-related synaptic changes focused on the toxic effects of amyloid. However, recent research suggests an emerging role for tau at the synapse. Even in the absence of tangles, mice overexpressing human tau display significant synaptic degeneration, suggesting that soluble, oligomeric tau is the synaptotoxic species. However, the localization of tau within synapses in both healthy and AD brains indicates that tau might play a role in normal synaptic function, which may be disrupted in disease. Tau is able to impact synaptic activity in several ways: studies show tau interacting directly with post-synaptic signaling complexes, regulating glutamatergic receptor content in dendritic spines, and influencing targeting and function of synaptic mitochondria. Early trials of tau-targeted immunotherapy reduce tau pathology and synapse loss, indicating that the toxic effects of tau may be reversible within a certain time frame. Understanding the role of tau in both normal and degenerating synapses is crucial for the development of therapeutic strategies designed to ameliorate synapse loss and prevent AD pathogenesis. This article is part of the Special Issue entitled 'The Synaptic Basis of Neurodegenerative Disorders'.

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2013.09.018

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.
Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,142
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Domain Interaction Between NMDA Receptor Subunits and the Postsynaptic Density Protein PSD-95
Kornau, H., Schenker, L. T., Kennedy, M. B., & Seeburg, P. H. (1995) · Science · doi:10.1126/science.7569905 · Cited by 1,916

Flagged first, then by citations

Show all 121 references

Sorted by citations

Items 101–200 of 204

Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Lam, S., Hérard, A., Boluda, S., Petit, F., Eddarkaoui, S., Cambon, K., The Brainbank Neuro-CEB Neuropathology Network, Letournel, F., Martin‐Négrier, M., Faisant, M., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01410-y · Cited by 29
Xanthoceraside prevented synaptic loss and reversed learning-memory deficits in APP/PS1 transgenic mice
Jin, G., Zhu, L., Liu, P., Xu, Q., Qi, Y. A., Zhou, X., Xu, J., Ji, X., Chi, T., & Zou, L. (2019) · The Journal of Physiological Sciences · doi:10.1007/s12576-019-00664-x · Cited by 22
Phlorizin administration ameliorates cognitive deficits by reducing oxidative stress, tau hyper‐phosphorylation, and neuroinflammation in a rat model of Alzheimer’s disease
Tian, Y., Lu, W., Deng, H., Yang, F., Guo, Y., Gao, L., & Xu, Y. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12644 · Cited by 21
The impact of anorexigenic peptides in experimental models of Alzheimer’s disease pathology
Maletı́nská, L., Popelová, A., Železná, B., Bencze, M., & Kuneš, J. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0532 · Cited by 21
Synaptic Localisation of Tau
Hanger, D. P., Goniotaki, D., & Noble, W. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_9 · Cited by 23
Self-citation
Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy
Popelová, A., Pražienková, V., Neprašová, B., Kasperová, B. J., Hrubá, L., Holubová, M., Zemenová, J., Blum, D. L., Železná, B., Galas, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171041 · Cited by 22
Dynamic structural determinants underlie the neurotoxicity of the N-terminal tau 26-44 peptide in Alzheimer's disease and other human tauopathies
Perini, G., Ciasca, G., Minelli, E., Papi, M., Palmieri, V., Maulucci, G., Nardini, M., Latina, V., Corsetti, V., Florenzano, F., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.08.220 · Cited by 21
Tau Spread, Apolipoprotein E, Inflammation, and More
Gonzalez, B. L., Abud, E. M., Abud, A. M., Poon, W. W., & Gylys, K. H. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.001 · Cited by 20
ChK1 activation induces reactive astrogliosis through CIP2A/PP2A/STAT3 pathway in Alzheimer's disease
Zhou, Y., Liu, X., Ma, S., Zhang, N., Yang, D., Wang, L., Ye, S., Zhang, Q., Ruan, J., Ma, J., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101625r · Cited by 18
Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer’s Disease
Su, M., Nizamutdinov, D., Liu, H., & Huang, J. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119272 · Cited by 26
An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease
Lizama, B. N., North, H. A., Pandey, K., Williams, C., Duong, D., Cho, E., Di Caro, V., Ping, L., Blennow, K., Zetterberg, H., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106575 · Cited by 19
Pharmacological inhibition of PTEN attenuates cognitive deficits caused by neonatal repeated exposures to isoflurane via inhibition of NR2B-mediated tau phosphorylation in rats
Tan, L., Chen, X., Wang, W., Zhang, J., Li, S., Zhao, Y., Wang, J., & Luo, A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.008 · Cited by 19
AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy
Borreca, A., Latina, V., Corsetti, V., Middei, S., Piccinin, S., Valle, F. D., Bussani, R., Ammassari‐Teule, M., Nisticò, R., Calissano, P., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0974-3 · Cited by 18
Protective effects of CCL01 against Aβ-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease
Ju, I. G., Son, S. Y., Lee, S.-M., Im, H., Huh, E., Eo, H., Choi, J. G., Sohn, M. W., Yim, S., Kim, S. Y., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114105 · Cited by 19
As a Potential Therapeutic Target, C1q Induces Synapse Loss Via Inflammasome-activating Apoptotic and Mitochondria Impairment Mechanisms in Alzheimer’s Disease
Guan, P.-P., Ge, T.-Q., & Wang, P. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10076-9 · Cited by 19
Improving Mouse Models for Dementia. Are All the Effects in Tau Mouse Models Due to Overexpression?Preprint
Joel, Z., Izquierdo, P., Salih, D. A. M., Richardson, J. C., Cummings, D. M., & Edwards, F. A. (2018) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2018.83.037531 · Cited by 18
The Role of the Urea Cycle in the Alzheimer's Disease Brain
Al‐Thani, N. A., Stewart, G. S., & Costello, D. A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70033 · Cited by 16
Clearing the way for tau immunotherapy in Alzheimer's disease
Herrmann, A. G., & Spires‐Jones, T. L. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12845 · Cited by 18
Longitudinal synaptic loss versus tau Braak staging in amnestic mild cognitive impairment
Vanderlinden, G., Koole, M. J. B., Michiels, L., Lemmens, R., Vandenbulcke, M., & Laere, K. V. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14412 · Cited by 18
Enduring and Sex-specific Changes in Hippocampal Gene Expression after a Subchronic Immune Challenge
Tchessalova, D., & Tronson, N. C. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2019.12.019 · Cited by 18
Tau mRNA is present in axonal RNA granules and is associated with elongation factor 1A
Malmqvist, T., Anthony, K., & Gallo, J. (2014) · Brain Research · doi:10.1016/j.brainres.2013.12.033 · Cited by 16
Increased extrasynaptic GluN2B expression is involved in cognitive impairment after isoflurane anesthesia
Li, L., Li, Z., Cao, Y., Fan, D., Chui, D., & Guo, X. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3306 · Cited by 17
Spreading of Pathology in Alzheimer’s Disease
Lv, Z., Tan, C., Yu, J., & Tan, L. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9765-2 · Cited by 15
Involvement of ‘stress–response’ kinase pathways in Alzheimer's disease progression
Mairet‐Coello, G., & Polleux, F. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.011 · Cited by 16
Amyloid Beta and Tau: from Physiology to Pathology in Alzheimer’s Disease
Khaledi, S., ایران, گ. ع. ز. د. ع. د. ک. س., Ahmadi, S., & ایران, گ. ع. ز. د. ع. د. ک. س. (2016) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.4.4.67 · Cited by 14
Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model
Zamarbide, M., Martínez‐Pinilla, E., Gil-Bea, F. J., Yanagisawa, M., Franco, R., & Pérez‐Mediavilla, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073533 · Cited by 13
Cerebrospinal fluid growth-associated protein 43 levels in patients with progressive and stable mild cognitive impairment
Lu, Y., & Initiative, A. D. N. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02202-z · Cited by 12
Can numerical modeling help understand the fate of tau protein in the axon terminal?
Kuznetsov, I. A., & Kuznetsov, A. V. (2015) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2014.994119 · Cited by 12
Molecular PET Imaging in Alzheimer’s Disease
Thientunyakit, T., Shiratori, S., Ishii, K., & Gelovani, J. G. (2022) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-022-00717-4 · Cited by 12
Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample
Rådestig, M. A., Skoog, I. G., Skillbäck, T. B., Zetterberg, H., Kern, J., Zettergren, A., Andréasson, U., Wetterberg, H., Kern, S., & Blennow, K. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01193-x · Cited by 11
Hexa (ethylene glycol) derivative of benzothiazole aniline promotes dendritic spine formation through the RasGRF1–Ras dependent pathway
Lee, N. J., Song, J. M., Cho, H.-J., Sung, Y. M., Lee, T., Chung, A., Hong, S., Cifelli, J. L., Rubinshtein, M., Habib, L. K., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.007 · Cited by 11
Impaired hippocampal and thalamic acetylcholine release in P301L tau-transgenic mice
Stein, C., Koch, K. A., Hopfeld, J., Lobentanzer, S., Lau, H., & Klein, J. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.07.014 · Cited by 11
MiR-219 deficiency in Alzheimer’s disease contributes to neurodegeneration and memory dysfunction through post-transcriptional regulation of tau-kinase networkPreprint
Arnés, M., Kim, Y. A., Lannes, J., Alaniz, M. E., Cho, J. D., McCabe, B. D., & Santa‐María, I. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/607176 · Cited by 11
Ethoprophos induces rats' brain injury and neurobehavioral impairment via transcriptional activation of glial fibrillary acidic protein and tubulin-associated unit even at the threshold inhibition of acetylcholinesterase: A 90-days study
Ibrahim, K. A., Abdelgaid, H. A., Eleyan, M., Khwanes, S. A., & Abdel‐Daim, M. M. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146216 · Cited by 9
A pathological phosphorylation pattern enhances tau cooperativity on microtubules and facilitates tau filament assembly
Fan, X., Truong, J. B., Okada, K., Lin, H., Ori-McKenney, K. M., & McKenney, R. J. (2026) · Communications Biology · doi:10.1038/s42003-026-10797-6 · Cited by 10
Early Chronic Stress Induced Changes within the Locus Coeruleus in Sporadic Alzheimer’s Disease
Minné, D., Marnewick, J. L., & Engel-Hills, P. C. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230811092956 · Cited by 10
Tau Protein as a Biological Fluid Biomarker in Neurodegenerative Dementias
Llorens, F., Villar‐Piqué, A., Candelise, N., Ferrer, I., & Zerr, I. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73528 · Cited by 10
Transmissible long-term neuroprotective and pro-cognitive effects of 1–42 beta-amyloid with A2T icelandic mutation in an Alzheimer’s disease mouse model
Célestine, M., Jacquier‐Sarlin, M. R., Borel, E., Petit, F., Lanté, F., Bousset, L., Hérard, A., Buisson, A., & Dhénain, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02611-8 · Cited by 7
Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy
Afrakoti, L. G. M. P., Moghadam, S. D., & Hadinezhad, P. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251329188 · Cited by 12
RNA Granules at the Crossroads of Synaptic Dysfunction and Neurodegeneration
Nóbrega‐Martins, R., Barros‐Santos, B., Papadimitriou, G., Sotiropoulos, I., Wolozin, B. L., & Silva, J. M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70269 · Cited by 8
Tau deposition and structural connectivity demonstrate differential association patterns with neurocognitive tests
Hall, Z., Chien, B., Zhao, Y., Risacher, S. L., Saykin, A. J., Wu, Y., & Wen, Q. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00531-7 · Cited by 7
Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer’s disease tau
Hromádková, L., Kim, C., Haldiman, T., Peng, L., Zhu, X., Cohen, M. L., de Silva, R., & Safar, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01133-0 · Cited by 6
Lateral Orbitofrontal Cortex and Basolateral Amygdala Regulate Sensitivity to Delayed Punishment during Decision-Making
Liley, A. E., Gabriel, D. B. K., & Simon, N. W. (2022) · eNeuro · doi:10.1523/eneuro.0170-22.2022 · Cited by 6
Imidazo[2,1]thiazol-3-one Derivatives Useful as Diagnostic Agents for Alzheimer’s Disease
Blass, B. E. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500147n · Cited by 6
hiPSC-neurons recapitulate the subtype-specific cell intrinsic nature of susceptibility to neurodegenerative disease-relevant aggregation
Weidling, I. W., Preiss, C. N., Chancellor, S. E., Srivastava, G. P., Gibilisco, L., Lin, G., Brennan, M. S., Lee, J. Y., Roth, L. M., Morozova, O., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02000-4 · Cited by 5
Bone Marrow-Derived Mesenchymal Stem Cells and γ-Secretase Inhibitor Treatments Suppress Amyloid-β25–35-Induced Cognitive Impairment in Rat Dams and Cortical Degeneration in Offspring
Gaber, A. M., El-Bakry, A. M., Aljàrari, R. M., Jaber, F. A., Khadrawy, Y. A., Sabry, D., Abo‐Eleneen, R. E., & Ahmed, O. M. (2023) · Stem Cells International · doi:10.1155/2023/2690949 · Cited by 5
The neuroinflammatory role of microRNAs in Alzheimer’s disease: pathological insights to therapeutic potential
Liu, W., Rao, X., Sun, W., Chen, X., Yu, L., Zhang, J., Chen, J., & Zheng, X. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05164-0 · Cited by 6
Association of DISC1 Polymorphisms with Late-Onset Alzheimer’s Disease in Northern Han Chinese
Zhang, X., Wang, H.-F., Tan, M., Wan, Y., Kong, L., Zheng, Z.-J., Tan, C., Zhang, W., Wang, Z., Tan, L., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9881-7 · Cited by 5
Serum concentration of beta amyloid peptide and the activity of angiotensin converting enzyme in alzheimers disease patients: search for a potential biomarker
Emadi, S., Aghababaee, L., & Maghbooli, M. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20160289 · Cited by 5
Multiple and Alternative Sites Make Tau Protein an Adaptable Sticky Surface for the SH3 Domain of Fyn Kinase
Tira, R., Leo, G., Prandini, L., Barracchia, C. G., D’Onofrio, M., Mollica, L., Capaldi, S., Assfalg, M., & Munari, F. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202504292 · Cited by 4
Performance of novel tau antibodies across multiple modalities for Alzheimer's disease assessment
Trivedi, P., Forrest, K., Fisher, D. W., Winstone, J. K., McMillan, P. J., Valentine, M., Postupna, N. O., Wilson, A. M., Bajwa, T. S., MacCoss, M. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70481 · Cited by 6
Proteomic Characterization of the Alzheimer’s Disease Risk Factor BIN1 Interactome
McMillan, J. D., Wang, S., Wohlfahrt, J., Guergues, J., Stevens, S. M., & Thinakaran, G. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101055 · Cited by 4
Effect of Genetic Risk on the Relationship Between rs-fMRI Complexity and Tau and Amyloid PET in Alzheimer’s Disease
Jann, K., Cen, S., Santos, M. D. V., Aksman, L., Wijesinghe, D., Zhang, R., Lynch, K. M., Ringman, J. M., Wang, D. J. J., & Initiative, A. D. N. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240459 · Cited by 4
Differential dysregulation of CREB and synaptic genes in transgenic Drosophila melanogaster expressing shaggy (GSK3), TauWT, or Amyloid-beta
Ataellahi, F., Masoudi, R., & Haddadi, M. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08059-9 · Cited by 4
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing micePreprint
Lam, S., Hérard, A., Boluda, S., Petit, F., Eddarkaoui, S., Cambon, K., The Brainbank Neuro-CEB Neuropathology Network, Picq, J., Buée, L., Duyckaerts, C. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.06.438654 · Cited by 4
Computational Insights into the Destabilization of Baicalein on the Tau Protofibrils Associated with Alzheimer’ s Disease and Chronic Traumatic Encephalopathy
Tang, J., Feng, D., Guan, L., Qi, B., & Zou, Y. F. (2025) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5c05778 · Cited by 3
Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia
Lorenzini, L., Ingala, S., Wottschel, V., Wink, A. M., Mutsaerts, H. J. M. M., Haller, S., Blennow, K., O'Brien, J. T., Frisoni, B. G., Chételat, G., et al. (2022) · Aging Brain · doi:10.1016/j.nbas.2022.100054 · Cited by 3
Regulation of neuronal mRNA splicing and Tau isoform ratio by ATXN3 through deubiquitylation of splicing factorsPreprint
Neves‐Carvalho, A., Duarte‐Silva, S., Silva, J. M., Meireles-Costa, L., Monteiro‐Fernandes, D., Correia, J. S., Rodrigues, B., Heetveld, S., Almeida, B., Savytska, N., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/711424 · Cited by 3
Distinct regional patterns of synaptic vulnerability across hippocampal and parahippocampal subregions in Alzheimer's disease
Bouwman, M. M. A., Frigerio, I., Graaf, Y. G.-D., van de Berg, W. D. J., & Jonkman, L. E. (2026) · Brain Pathology · doi:10.1111/bpa.70081 · Cited by 4
The role of neurogenesis in neurodegenerative diseases: Mechanisms and interventions
Chen, R., Qiu, Z., Luo, Y., Fu, Y., Cui, X., & Jiang, M. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103160 · Cited by 2
Report from the Tau Front: Cantoblanco 2013
Hall, G. F. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000e133 · Cited by 2
Atualização no estudo das bases bioquímicas e moleculares da doença de Alzheimer/ An update about the biochemical and molecular basis of Alzheimer's disease
Dalmagro, A. P., Cazarin, C. A., & Zenaide, F. D. S. (2020) · Brazilian Applied Science Review · doi:10.34115/basrv4n1-008 · Cited by 2
Mesenchymal Stem Cells and Begacestat Mitigate Amyloid-β 25–35-Induced Cognitive Decline in Rat Dams and Hippocampal Deteriorations in Offspring
Gaber, A. M., Ahmed, O. M., Khadrawy, Y. A., Zoheir, K. M. A., Abo‐Eleneen, R. E., Alblihed, M. A., & El-Bakry, A. M. (2023) · Biology · doi:10.3390/biology12070905 · Cited by 2
Biomarkers for Alzheimer's Disease
Panwar, D., Sharma, P., Sharma, S., Malik, M., & Kaur, J. (2024) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/979-8-3693-6442-0.ch003 · Cited by 1
Small noncoding RNAs: Pioneering a new therapeutic era in Alzheimer’s disease
Sahoo, S., Pattanaik, S., Kar, D. M., Prusty, S. K., & Sahu, P. K. (2025) · Gene · doi:10.1016/j.gene.2025.149827 · Cited by 1
Acetyl-11-keto-β-boswellic acid attenuates tau oligomer-induced neurotoxicity in neuroblastoma cell model
Pourhossein, S., Mianrood, I. B., Khatami, S. H., Ehtiati, S., Ghasemian, M., Mokhtari, F., Ahmadzade, R., Goudarzi, M., Hamed, N. A., Namvarjah, F., et al. (2026) · BMC Neuroscience · doi:10.1186/s12868-026-00996-6 · Cited by 1
Gene therapy targeting synaptopathy linked with Alzheimer’s and Parkinson’s disease
Panda, S. P., Saraswat, N., & Singh, V. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.02.035 · Cited by 1
A positive association between phosphorylated Tau217 (pTau217) and neural correlations is prevented by human leukocyte antigen allele DRB1*13:01
James, L. M., Stratigopoulos, G., Leuthold, A. C., & Georgopoulos, A. P. (2026) · Scientific Reports · doi:10.1038/s41598-026-44894-7 · Cited by 1
Schizophrenia and frontotemporal dementia: distinct diseases with converging circuit dysfunctions
Casile, A., Sapienza, J., Vasciaveo, V., Barzon, B., Nasini, S., Guarato, G., Ave, C., Martini, F., Bosia, M., & Comai, S. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.04.003 · Cited by 1
Spinosin protects Neuro-2a/APP695 cells from oxidative stress damage by inactivating p38.
Xiaoying, Z., Ruixuan, W., Yiqing, W., Fanxing, X. U., Tingxu, Y., Wu, B., Zhang, M., & Jia, Y. (2023) · PubMed Central · doi:10.19852/j.cnki.jtcm.20220907.001 · Cited by 1
Wherefore Art Tau? Functional importance of site-specific tau phosphorylation in diverse subcellular domains
Schneeweis, A. K., & Pak, D. T. S. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106475 · Cited by 1
AENK ameliorates cognitive impairment and prevents Tau hyperphosphorylation through inhibiting AEP ‐mediated cleavage of SET in rats with ischemic stroke
Liu, Y., Liu, W., Guo, C., Bao, J., Zhang, H., Li, W., Li, Y., Gui, Y., Zeng, Y., Wang, X., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16283 · Cited by 1
Multiple and Alternative Sites Make Tau Protein an Adaptable Sticky Surface for the SH3 Domain of Fyn Kinase
Tira, R., Leo, G., Prandini, L., Barracchia, C. G., D’Onofrio, M., Mollica, L., Capaldi, S., Assfalg, M., & Munari, F. (2025) · Angewandte Chemie · doi:10.1002/ange.202504292 · Cited by 1
Role of Immunotherapy in Ameliorating Proteopathic Dementia
Singh, M., Pancham, P., Agarwal, S., Kaur, H., Agarwal, V., Tiwari, R. K., Mani, S., & Rachana, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_16 · Cited by 1
Dendritic spines are lost in clusters in Alzheimer’s diseasePreprint
Mijalkov, M., Volpe, G., Fernaud-Espinosa, I., DeFelipe, J., Pereira, J. B., & Merino‐Serrais, P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.20.346718 · Cited by 1
Faculty Opinions recommendation of Tau kinetics in neurons and the human central nervous system.
Millan, M. J. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732876856.793545483 · Cited by 1
Compensatory Plasticity Defines a Vulnerable Neuronal State in Alzheimer’s Disease with PsychosisPreprint
Victor, M. B., Sun, N., Galani, K., Leary, N., Tanigawa, Y., Scannail, A. N., Ho, L., Prosper, S., Liu, L., Kofler, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.30.651435 · Cited by 1
Caracterização das alterações na via hipocampo-córtex pré-frontal medial em modelo farmacológico da doença de Alzheimer
Esteves, I. D. M. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2016.tde-26082016-110343
Optimization and Utilization of Hybrid Culture Between Rat and Fly Primary Neurons: A Novel Model for Studying Neurodegenerative Diseases
Kraus, K. L. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
In Vitro Characterization of Unmodified and Pyroglutamylated Alzheimer's Amyloid beta peptide
Matos, J. O. (2014) · Journal of International Crisis and Risk Communication Research
Investigating the contribution of astrocytes and neuroinflammation to pathological tau changes in Alzheimer's disease
Phillips, E. C. (2017) · Research Portal (King's College London)
Análisis de la memoria visual y verbal en la demencia tipo Alzheimer leve
Pereira, G. E. P. (2016) · Gredos (University of Salamanca) · doi:10.14201/gredos.132819
Effect of Seizure During Pregnancy on Cognitive and Motor Coordination Performances in Adult Male Offspring of Female Mice: The Role of Serum Corticosterone Level
Sabaghi, A., Heyrani, A., Kiani, A., Khazaee, H., Sabaghi, S., & Beygie, S. (2019) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.7.4.8
Tau proteolysis mechanisms and relevance for tauopathies
Quinn, J. P. (2019) · Research Explorer (The University of Manchester)
Positron emission tomography imaging agents for evaluating the pathologic features of Alzheimer's disease and drug development
Huang, Y. H., Jia, H., & Bao, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00013-6
ROLE OF PATHOGENIC PROTEINS AND CHRONIC INFLAMMATION IN THE OCCURRENCE OF ALZHEIMER'S DISEASE
Denysenko, A., Haikova, O. O., & Moskalenko, R. (2020) · Eastern Ukrainian Medical Journal · doi:10.21272/eumj.2020;8(4):475-490
α-synuclein disrupts neuron network rhythmic activity when overexpressed in cultured neurons
Leite, K. (2021) · doi:10.53846/goediss-8468
Cerebrospinal fluid biomarkers and cognition in older adults
Rådestig, M. A. (2021)
Dancing with Glia: The Role of Astrocytes, Microglia and Oligodendrocytes and their Relation with Neurons in Neuroinflammation and Aging
Bellini, M. J. (2020) · Open Access Journal of Biomedical Science · doi:10.38125/oajbs.000238
Ce que la neuropathologie nous a appris ces 20 dernières années sur les maladies cérébrales à expression cognitive
Deramecourt, V. (2022) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2022.01.014
Aberrant Hydrogen Sulfide Signaling in A lzheimer's Disease
Paul, B. D. (2022) · Wiley eBooks · doi:10.1002/9781119799900.ch18
A Review on the Role of Neuroplasticity in Neurodegenerative Disorders and Its Possible Pharmacological and Non-Pharmacological Interventions
Aslam, R. M. N., Noor‐ul‐Ain, Ali, H., Muzammil, A., & Iqbal, A. (2024) · Asian Journal of Medicine and Health · doi:10.9734/ajmah/2024/v22i1977
Prodrugs for neurodegenerative diseases
Guglielmi, P., Granese, A., Secci, D., & Chimenti, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15635-9.00011-0
Bibliometric analysis of pathological mechanisms in Alzheimer's disease: Applications based on mouse models
Li, J., Lin, Z., Niu, Y., Chang, W., Song, S., Yang, G., Liu, F., Dai, J., & Hao, C. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251367046
Additional file 1 of Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Lam, S., Hérard, A., Boluda, S., Petit, F., Eddarkaoui, S., Cambon, K., Picq, J., Buée, L., Duyckaerts, C. J., Haı̈k, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20502025
Additional file 1 of Microglia degrade Tau oligomers deposit via purinergic P2Y12-associated podosome and filopodia formation and induce chemotaxis
Chinnathambi, S., & Das, R. (2024) · Figshare · doi:10.6084/m9.figshare.26591393
Studies on the Role of Cellular Heparan Sulfate on Tau Pathology in Alzheimer's Disease and Related Tauopathies
Sepulveda-Diaz, J. E. (2013) · theses.fr (ABES) · doi:10.70675/56c42bcbz41dfz432bzbb78z77110b373285
Plasticity of hippocampal synaptic transmission and intrinsic excitability in a mouse model of Alzheimer’s disease
Jiang, N. (2019) · theses.fr (ABES) · doi:10.70675/e788b268zc8e3z491az8d02z52080880e988
Implication of 3S-HS and HS3ST2 in synaptic stability under physiological conditions and in Alzheimer's disease-related tauopahty
Maïza, A. (2019) · theses.fr (ABES) · doi:10.70675/85b6b166z912fz42acza589z62dfb17d5a4e
Transmission of Alzheimer pathology in murine and primate models : from proteinopathies to neuronal and cognitive impairments
Lam, S. (2021) · theses.fr (ABES) · doi:10.70675/60b353ffz56fcz41a2z9e53zf0d9ac078167 · Cited by 1

Authors: Pooler, A. M., Noble, W., & Hanger, D. P.
Affiliations: King's College London (GB)
Corresponding author: Hanger, Diane P.
ORCID: Pooler, Amy M.
Noble, Wendy
Hanger, Diane P.
Venue: Neuropharmacology
Publisher: Elsevier BV
Published: 2014-01
Volume: 76
Pages: 1-8
ISSN: 0028-3908 (ISSN-L)
DOI: 10.1016/j.neuropharm.2013.09.018
OpenAlex: W1972886222
Cited by: 203
References: 121
Citations by year: 2026: 8 · 2025: 14 · 2024: 10 · 2023: 15 · 2022: 16 · 2021: 17 · 2020: 20 · 2019: 20 · 2018: 18 · 2017: 13 · 2016: 20 · 2015: 15 · 2014: 15
FWCI: 1.91
Type: journal article
Language: en
Open access: closed
Locations: Neuropharmacology (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: Wellcome Trust
Medical Research Council
Biotechnology and Biological Sciences Research Council
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: tau protein, Alzheimer's disease, synaptic degeneration, tau oligomers, synaptotoxicity, synaptic mitochondria, glutamate receptors, dendritic spines, cognitive decline
MeSH terms: Alzheimer Disease, Animals, Humans, Mitochondria, Models, Neurological, Nerve Degeneration, Nerve Tissue Proteins, Synaptic Transmission, Signal Transduction, Amyloid beta-Peptides, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A role for tau at the synapse in Alzheimer’s disease pathogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks